テレ東BIZ ダイジェスト banner
テレ東BIZ ダイジェスト avatar
テレ東BIZ ダイジェスト
@tvtokyobiz
Subscribers2.6M
Views2.6B
Videos55.4K
テレ東BIZ ダイジェストPublished at May 29, 2026 at 11:41 AM0:46
健康保険法改正案 参院で可決・成立へ OTC類似薬で25%の追加負担 thumbnail

健康保険法改正案 参院で可決・成立へ OTC類似薬で25%の追加負担

8 days agoActive window
otcshorts
Published time
May 29, 2026 at 11:41 AM
Duration
0:46
Video type
News & Politics
Channel region
Japan
Publish Timing Insight
Not enough timing data
This channel still lacks enough historical upload timing data. Let the channel accumulate more snapshots before evaluating the best timing.
Monetization Insight
No clear monetization tags yet
Focus on view growth, engagement quality, and topic competition to judge monetization potential.
Action Suggestion
Watch for sustained growth
The basic conditions are already in place. Keep watching 7-day views and revenue before deciding whether this topic should become a series.
Views
7.5K
Likes
93
Comments
19
Estimated Daily Revenue
$0.01 - $0.05
Estimated Total Revenue
$0.18 - $0.72
RPM Range
$0.02 - $0.1
1D Views Gain
0
7D Views Gain
0
1D Likes Gain
0
7D Likes Gain
0
1D Comments Gain
0
7D Comments Gain
0
Velocity Score
0%
Topic Cluster
otc
Video Description
市販薬の成分に似た薬の処方に対する患者の追加負担を盛り込んだ健康保険法などの改正案が、このあとの参議院本会議で、与党などの賛成多数で可決・成立する見通しです。改正案では、市販薬と効能が似て自己負担額が少ない「OTC類似薬」を処方された患者に対し薬剤費の25%の追加負担を求めるとしています。ただ、がんや難病の患者など配慮が必要な人には新たな負担を求めない方針です。また、医療が高額になった患者の自己負担を抑える「高額療養費制度」については、長期療養者の家計への影響を考慮することが明記されています。 #健康保険法 #改正案 #参議院 #市販薬 #OTC類似薬 #高額療養費制度 #がん #難病 仕事や投資に役立つ経済メディア『テレ東BIZ』。 WBSやモーサテほか、他では見られない記者解説やオリジナル番組が充実 ▼▼「テレ東BIZ」はこちら▼▼ https://txbiz.tv-tokyo.co.jp/lp/?utm_source=youtube&utm_medium=video
Related Topics
Continue with closely related videos to judge topic depth and content format.
Topic: otc
Not enough related-topic video data yet.
Video FAQs

These FAQs clarify what this video page measures, why revenue is estimated, and how to use the page for content research.

What can you learn from this video analytics page?

This page shows views, likes, comments, RPM and revenue estimates, publish timing, topic tags, related videos, and the broader channel context behind the video.

Why are RPM and revenue numbers estimates?

Actual earnings depend on monetized playbacks, audience geography, seasonality, advertiser demand, and monetization status. CloutOrbit provides directional estimates for benchmarking, not exact payouts.

How should you use this page for content research?

Compare timing, topic tags, monetization signals, and adjacent videos from the same channel to spot formats, themes, and publishing patterns worth testing.